Its mechanism is to inhibit NETs formation, reduce neutrophil recruitment and MPO expression in the liver and MDSCs in the lung and tumor by blocking P-selectin, inhibiting NF-κB and STAT3 signalling pathways. This evidence concerns the gene SELP and neoplasm.